皮膚病藥物全球市場規模調查和預測，按適應症（痤瘡、牛皮癬、酒渣鼻、脫髮等），區域分析，2022-2029 年

2021 年全球皮膚病治療市場價值約為 170 億美元，預計在 2022-2029 年預測期內將以超過 10.8% 的健康增長率增長。

皮膚科藥物是用於治療各種皮膚病的藥物物質，其直接關注的是皮膚護理。 各種皮膚病，如痤瘡、斑禿、天皰瘡，都是用皮膚科藥物治療的。 皮膚病學治療的重點是治療和預防皮膚病。 推動市場增長的因素包括對皮膚病的研究、對皮膚病認識的提高、對創新產品的需求增加、治療藥物的批准、研發投資的增加以及可支配收入的增加。它是

根據 Health, Pharma & MedTech 的數據，到 2021 年，大約 23% 的印度受訪者將患有痤瘡和頭皮屑等皮膚病。 根據美國皮膚病學會的數據，大約 85% 的 12 至 24 歲成年人患有輕度痤瘡。 皮膚病的日益流行推動了皮膚病藥物市場的增長。 此外，2023年全球護膚品市場規模約為187.1億日元，其中大部分將發生在美國。 皮膚病治療的增加表明人們對皮膚病的認識不斷提高，推動了市場增長。 推動市場擴張的其他關鍵因素包括對創新產品的需求增加、治療藥物的批准、研發投資的增加以及可支配收入的增加。 此外，醫療保健支出的增加和製藥行業的擴張是創造重要市場機會的因素。 然而，替代品的可用性阻礙了整個 2022-2029 年預測期內的市場增長。

全球皮膚病治療市場研究考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 歐洲有大量皮膚病患者，正在推進地下儲氫，政府加大對發展儲氫設施的投資，加大對醫療保健領域的投資，該地區的氫能源在市場上佔據主導地位因投資增加而產生的收益 由於技術進步、實時數據傳輸、天然氣部署意識增強以及對政府法規的支持等因素，預計北美在預測期內將以最高複合年增長率增長。

內容

第 1 章執行摘要

• 市場概況
• 2019-2029 年全球和細分市場估計和預測
  • 2019-2029 年按地區劃分的皮膚病藥物市場
  • 皮膚病藥物市場，按適應症，2019-2029 年
• 主要趨勢
• 調查方法
• 調查先決條件

第 2 章。全球皮膚病治療市場的定義和範圍

• 調查目的
• 市場定義和範圍
  • 調查範圍
  • 工業發展
• 本次調查涵蓋的年份
• 貨幣兌換率

第3章全球皮膚病藥物市場動態

• 皮膚科藥物市場影響分析 (2019-2029)
  • 市場驅動因素
    • 增加粗糙皮膚
    • 提高對皮膚病的認識
  • 市場挑戰
    • 備選方案的可用性
  • 市場機會
    • 不斷上漲的醫療費用
    • 醫藥行業的發展

第 4 章全球皮膚病治療市場：行業分析

• 波特 5 力模型
  • 供應商的議價能力
  • 買家的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的敵對關係
• 波特 5 力模型的未來方法 (2019-2029)
• 害蟲分析
  • 政治
  • 經濟的
  • 社交
  • 技術
• 投資招聘模式
• 分析師的建議和結論
• 主要投資機會
• 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

• 評估 COVID-19 對行業的總體影響
• COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球皮膚科市場：按適應症分類

• 市場概況
• 全球皮膚病藥物市場：按適應症、按性能 - 潛力分析
• 2019-2029 年全球皮膚病藥物市場的適應症估計和預測
• 皮膚科藥物市場、細分市場分析
  • 痤瘡
  • 銀屑病
  • 酒渣鼻
  • 脫髮
  • 其他

第 7 章。全球皮膚病藥物市場：區域分析

• 皮膚病治療市場：按地區劃分的市場概況
• 北美
  • 美國
    • 2019-2029 年各適應症的估計和預測
  • 加拿大
• 歐洲皮膚病藥物市場概況
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 意大利
  • 其他歐洲
• 亞太地區皮膚病治療市場概況
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 其他亞太地區
• 拉丁美洲皮膚病藥物市場概況
  • 巴西
  • 墨西哥
• 世界其他地方

第 8 章衝突信息

• 頂級市場策略
• 公司簡介
  • 諾華公司
    • 關鍵信息
    • 概覽
    • 財務（僅當數據可用時）
    • 產品概覽
    • 近期趨勢
  • Amgen Inc
  • AbbVie Inc
  • Johnson & Johnson Private Limited
  • Leo Pharma A/S
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • AstraZeneca plc
  • Pfizer Inc
  • Merck KGaA

第九章研究過程

• 研究過程
  • 數據挖掘
  • 分析
  • 市場評估
  • 驗證
  • 出版
• 調查的特點
• 調查先決條件

Global Dermatological Drugs Market is valued at approximately USD 17.0 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.8% over the forecast period 2022-2029. Dermatological drugs are medical substances used to treat a variety of skin disorders and their direct concern is skin care. Various skin disorders such as Acne, Alopecia Areata, Pemphigus, and more are treated through dermatological drugs. The focus of Dermatological drugs is to cure and prevent skin disorders. Increasing skin conditions, growing awareness regarding skin diseases, increasing demand for innovative products, approval of drugs for treatment, increasing investment in research and development, and increasing disposable income are the factors driving the growth of the market.

According to Health, Pharma & MedTech, in India, around 23% of the respondents suffered from skin conditions such as acne and dandruff in 2021. According to the American Academy of Dermatology Association, around 85% of adult people aged between 12 to 24 experience minor acne. The increasing prevalence of skin conditions results in the growth of the dermatological drugs market. Additionally, the global skin treatment in 2023 was valued at around 18.71 billion, most of which is generated in the US. Increasing treatment of skin conditions shows the increasing awareness of skin diseases which drives the market growth. Other important components driving market increase are increasing demand for innovative products, approval of drugs for treatment, increasing investment in research and development, and increasing disposable income. Furthermore, an increase in healthcare expenditure and the Development of the pharmaceutical industry are the factors creating major market opportunities. However, the availability of alternatives stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Dermatological Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Europe dominated the market in terms of revenue, owing to the high number of patients with skin diseases, increasing underground hydrogen storage adoption, increasing government investment in the development of hydrogen storage capacities, rising investments in the healthcare sector, and the region's increasing investment in hydrogen energy. North America is expected to grow with the highest CAGR during the forecast period, owing to factors such as technological advancements, real-time data delivery, Increasing awareness regarding the adoption of natural gas and, supportive government regulations

Major market players included in this report are:

• Novartis AG
• Amgen Inc
• AbbVie Inc
• Johnson & Johnson Private Limited
• Leo Pharma A/S
• Eli Lilly and Company
• GlaxoSmithKline Plc
• AstraZeneca plc
• Pfizer Inc
• Merck KGaA

Recent Developments in the Market:

• In July 2021, TWYNEO cream of Sol-Gel Technologies Ltd was approved by US FDA for the treatment of acne vulgaris.
• In June 2021, Kyowa Kirin Co., Ltd. and Amgen have agreed to work together to develop and market KHK4083 for the treatment of skin diseases such as atopic dermatitis.

Global Dermatological Drugs Market Report Scope:

• Historical Data 2019-2020-2021

• Base Year for Estimation 2021

• Forecast period 2022-2029

• Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

• Segments Covered Indication, Region

• Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

• Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Indication offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Indication:

• Acne
• Psoriasis
• Rosacea
• Alopecia
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Dermatological Drugs Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Dermatological Drugs Market, by Indication, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Dermatological Drugs Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Dermatological Drugs Market Dynamics

• 3.1. Dermatological Drugs Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing skin conditions
    • 3.1.1.2. Growing awareness regarding skin diseases
  • 3.1.2. Market Challenges
    • 3.1.2.1. Availability of alternatives
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increase in healthcare expenditure
    • 3.1.3.2. Development of the pharmaceutical industry

Chapter 4. Global Dermatological Drugs Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Dermatological Drugs Market, by Indication

• 6.1. Market Snapshot
• 6.2. Global Dermatological Drugs Market by Indication, Performance - Potential Analysis
• 6.3. Global Dermatological Drugs Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
• 6.4. Dermatological Drugs Market, Sub Segment Analysis
  • 6.4.1. Acne
  • 6.4.2. Psoriasis
  • 6.4.3. Rosacea
  • 6.4.4. Alopecia
  • 6.4.5. Others

Chapter 7. Global Dermatological Drugs Market, Regional Analysis

• 7.1. Dermatological Drugs Market, Regional Market Snapshot
• 7.2. North America Dermatological Drugs Market
  • 7.2.1. U.S. Dermatological Drugs Market
    • 7.2.1.1. Indication breakdown estimates & forecasts, 2019-2029
  • 7.2.2. Canada Dermatological Drugs Market
• 7.3. Europe Dermatological Drugs Market Snapshot
  • 7.3.1. U.K. Dermatological Drugs Market
  • 7.3.2. Germany Dermatological Drugs Market
  • 7.3.3. France Dermatological Drugs Market
  • 7.3.4. Spain Dermatological Drugs Market
  • 7.3.5. Italy Dermatological Drugs Market
  • 7.3.6. Rest of Europe Dermatological Drugs Market
• 7.4. Asia-Pacific Dermatological Drugs Market Snapshot
  • 7.4.1. China Dermatological Drugs Market
  • 7.4.2. India Dermatological Drugs Market
  • 7.4.3. Japan Dermatological Drugs Market
  • 7.4.4. Australia Dermatological Drugs Market
  • 7.4.5. South Korea Dermatological Drugs Market
  • 7.4.6. Rest of Asia Pacific Dermatological Drugs Market
• 7.5. Latin America Dermatological Drugs Market Snapshot
  • 7.5.1. Brazil Dermatological Drugs Market
  • 7.5.2. Mexico Dermatological Drugs Market
• 7.6. Rest of The World Dermatological Drugs Market

Chapter 8. Competitive Intelligence

• 8.1. Top Market Strategies
• 8.2. Company Profiles
  • 8.2.1. Novartis AG
    • 8.2.1.1. Key Information
    • 8.2.1.2. Overview
    • 8.2.1.3. Financial (Subject to Data Availability)
    • 8.2.1.4. Product Summary
    • 8.2.1.5. Recent Developments
  • 8.2.2. Amgen Inc
  • 8.2.3. AbbVie Inc
  • 8.2.4. Johnson & Johnson Private Limited
  • 8.2.5. Leo Pharma A/S
  • 8.2.6. Eli Lilly and Company
  • 8.2.7. GlaxoSmithKline Plc
  • 8.2.8. AstraZeneca plc
  • 8.2.9. Pfizer Inc
  • 8.2.10. Merck KGaA

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Dermatological Drugs Market, report scope
• TABLE 2. Global Dermatological Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Dermatological Drugs Market estimates & forecasts by Indication 2019-2029 (USD Billion)
• TABLE 4. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 5. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. U.S. Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 16. U.S. Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. Canada Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 18. Canada Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. UK Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 21. UK Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. Germany Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 24. Germany Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. France Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 27. France Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. Italy Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 30. Italy Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Spain Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 33. Spain Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. RoE Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 36. RoE Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. China Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 39. China Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. India Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 42. India Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. Japan Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 45. Japan Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. South Korea Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 48. South Korea Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. Australia Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 51. Australia Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. RoAPAC Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. Brazil Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 57. Brazil Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Mexico Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 60. Mexico Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. RoLA Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 63. RoLA Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. Row Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 66. Row Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. List of secondary sources, used in the study of global Dermatological Drugs Market
• TABLE 69. List of primary sources, used in the study of global Dermatological Drugs Market
• TABLE 70. Years considered for the study
• TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Dermatological Drugs Market, research methodology
• FIG 2. Global Dermatological Drugs Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Dermatological Drugs Market, key trends 2021
• FIG 5. Global Dermatological Drugs Market, growth prospects 2022-2029
• FIG 6. Global Dermatological Drugs Market, porters 5 force model
• FIG 7. Global Dermatological Drugs Market, pest analysis
• FIG 8. Global Dermatological Drugs Market, value chain analysis
• FIG 9. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Dermatological Drugs Market, regional snapshot 2019 & 2029
• FIG 15. North America Dermatological Drugs Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Dermatological Drugs Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Dermatological Drugs Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Dermatological Drugs Market 2019 & 2029 (USD Billion)
• FIG 19. Global Dermatological Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable